VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MIST
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MISTMilestone Pharmaceuticals Inc.
$1.29$111M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMISTQuarterly Financials

Milestone Pharmaceuticals Inc. (MIST) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Milestone Pharmaceuticals Inc. (MIST) quarterly income statement — complete revenue, gross profit & net income history

MIST Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue238K1.55M00000000001M3.5M1.5M000015M
Revenue Growth %---------100%-100%-100%-----100%----
Cost of Goods Sold70K025K00000000000000292K9.73M0
COGS % of Revenue29.41%-------------------
Gross Profit168K1.55M-25K0000000001M3.5M1.5M00-292K-9.73M15M
Gross Margin %70.59%100%----------100%100%100%----100%
Gross Profit Growth %---------100%-100%-100%--1298.63%115.41%-100%--224.44%-18.29%273.97%
Operating Expenses23.94M18.8M11.88M12.53M20.52M12.35M9.62M9.66M10.48M13.8M15.36M16.44M16.5M17.26M16.53M16.81M14.05M16.71M4.54M14.29M
OpEx % of Revenue10058.82%1216.24%----------1650.2%493.11%1102%----95.25%
Selling, General & Admin4.82M13.28M7.86M8.86M15.54M8.41M5.65M6.85M6.84M8.35M8.64M7.81M6.25M6.19M6.7M6.15M5.28M5.8M4.54M4.86M
SG&A % of Revenue2026.89%859.12%----------624.5%176.89%446.93%----32.41%
Research & Development3.36M5.52M4.01M3.67M4.98M3.94M3.96M2.81M3.64M5.45M6.72M8.62M10.26M10.71M9.83M10.66M8.77M10.9M9.93M9.51M
R&D % of Revenue1411.76%357.12%----------1025.7%306.11%655.07%----63.43%
Other Operating Expenses1000K000000000000354K0000-1000K-87K
Operating Income-23.77M-17.26M-11.9M-12.53M-20.52M-12.35M-9.62M-9.66M-10.48M-13.8M-15.36M-16.44M-15.5M-13.76M-15.03M-16.81M-14.05M-17M-14.27M712K
Operating Margin %-9988.24%-1116.24%-----------1550.2%-393.11%-1002%----4.75%
Operating Income Growth %-15.83%-39.76%-23.77%-29.69%-95.9%10.52%37.4%41.21%32.42%-0.3%-2.2%2.2%-10.36%19.06%-5.3%-2460.39%-11.54%-94%-18.11%105.43%
EBITDA-23.72M-17.22M-11.88M-12.5M-20.5M-12.32M-9.59M-9.64M-10.45M-13.77M-15.34M-16.41M-15.48M-13.74M-15M-16.78M-14.02M-16.71M-14.25M735K
EBITDA Margin %-9964.71%-1114.04%-----------1548.4%-392.69%-1000.2%----4.9%
EBITDA Growth %-15.71%-39.77%-23.83%-29.75%-96.17%10.54%37.46%41.29%32.52%-0.22%-2.22%2.2%-10.41%17.73%-5.29%-2383.27%-11.56%-92.64%-18.13%105.62%
D&A (Non-Cash Add-back)56K34K25K28K27K26K25K26K28K26K24K24K18K15K27K24K23K292K24K23K
EBIT-23.77M-16.42M-11.03M-12.02M-19.83M-11.44M-8.54M-8.48M-9.48M-12.75M-14.24M-15.22M-14.92M-13.76M-14.56M-16.65M-14.05M-16.96M-14.27M712K
Net Interest Income-2.4M-152K-93K-435K-238K-15K177K299K122K189K279K393K552K582K474K158K40K34K48K58K
Interest Income1.73M833K874K516K697K904K1.08M1.19M994K1.05M1.12M1.21M585K582K474K158K40K34K48K58K
Interest Expense4.13M985K967K951K935K919K903K887K872K857K841K820K33K0000000
Other Income/Expense-2.4M-152K-93K-435K-238K-15K177K299K122K189K279K393K552K582K474K158K40K34K48K58K
Pretax Income-26.18M-17.41M-11.99M-12.97M-20.76M-12.36M-9.44M-9.36M-10.35M-13.61M-15.08M-16.04M-14.95M-13.18M-14.56M-16.65M-14.01M-16.96M-14.22M770K
Pretax Margin %-10997.9%-1126.07%-----------1495%-376.49%-970.4%----5.13%
Income Tax-109K0-73K00000000000000-80K00
Effective Tax Rate %0.42%0%0.61%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0.47%0%0%
Net Income-26.07M-17.41M-11.92M-12.97M-20.76M-12.36M-9.44M-9.36M-10.35M-13.61M-15.08M-16.04M-14.95M-13.18M-14.56M-16.65M-14.01M-16.88M-14.22M770K
Net Margin %-10952.1%-1126.07%-----------1495%-376.49%-970.4%----5.13%
Net Income Growth %-25.55%-40.82%-26.31%-38.48%-100.51%9.17%37.41%41.64%30.74%-3.29%-3.61%3.63%-6.73%21.96%-2.33%-2262.08%-11.93%-94.83%-18.75%105.93%
Net Income (Continuing)-26.07M-17.41M-11.92M-12.97M-20.76M-12.36M-9.44M-9.36M-10.35M-13.61M-15.08M-16.04M-14.95M-13.18M-14.56M-16.65M-14.01M-16.88M-14.22M770K
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.20-0.16-0.12-0.20-0.31-0.20-0.14-0.14-0.21-0.41-0.35-0.37-0.350.43-0.33-0.39-0.33-0.40-0.340.02
EPS Growth %35.48%20%14.29%-42.86%-47.62%51.22%60%62.16%40%-195.35%-6.06%5.13%-6.06%207.5%2.94%-2050%-10%-37.93%15%103.77%
EPS (Basic)-0.20-0.16-0.12-0.20-0.31-0.20-0.14-0.14-0.21-0.41-0.35-0.37-0.350.43-0.33-0.39-0.33-0.40-0.340.02
Diluted Shares Outstanding130.29M83.88M66.38M66.38M66.29M62.21M66.19M66.17M50.16M33.48M42.97M42.94M42.85M42.78M42.49M42.28M42.24M42.18M42.19M44.53M
Basic Shares Outstanding130.29M83.88M66.38M66.38M66.29M62.21M66.19M66.17M50.16M33.48M42.97M42.94M42.85M42.78M42.49M42.28M42.24M42.18M42.19M41.67M
Dividend Payout Ratio--------------------